Evidence map›Paper›PMID 35044751›Full record

ArticleJournal of the American Chemical Society2022

Total Syntheses of Scabrolide A and Nominal Scabrolide B.

Zhanchao Meng, Alois Fürstner

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Asymmetric Total Synthesis of (+)-Ineleganolide.Angewandte Chemie (International ed. in English) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. An Enantiospecific Synthesis of 5-Molecules (Basel, Switzerland) · 2023
    Article
  8. A Convergent Total Synthesis of (+)-Ineleganolide.Journal of the American Chemical Society · 2023
    Article
  9. Total Syntheses of Nominal and Actual Prorocentin.Journal of the American Chemical Society · 2023
    Article
  10. Asymmetric Total Synthesis of Havellockate.Journal of the American Chemical Society · 2022
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Zhanchao MengMax-Planck-Institut für Kohlenforschung, 45470 Mülheim/Ruhr, Germany.
Alois FürstnerMax-Planck-Institut für Kohlenforschung, 45470 Mülheim/Ruhr, Germany.ORCID 0000-0003-0098-3417

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The marine natural product scabrolide A was obtained by isomerization of the vinylogous 1,4-diketone entity of nominal scabrolide B as the purported pivot point of the biosynthesis of these polycyclic norcembranoids. Despite the success of this maneuver, the latter compound itself turned out not to be identical with the natural product of that name. The key steps en route to the carbocyclic core of these targets were a [2,3]-sigmatropic rearrangement of an allylic sulfur ylide to forge the overcrowded C12-C13 bond, an RCM reaction to close the congested central six-membered ring, and a hydroxy-directed epoxidation/epoxide opening/isomerization sequence to set the "umpoled" 1,4-dicarbonyl motif and the correct angular configuration at C12.

Identifiers

PMID35044751
PMCPMC8815080

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.